Search for Clinical Trial Results

Sponsored By

Pelvic Neoplasms - 25 Studies Found

Status Study
Recruiting Study Name: Repeat CT Scans for Evaluation of Inter- and Intrafraction Motion and it's Effect on Radiotherapy Dose Distribution During Curative Radiotherapy for Pelvic Tumours
Condition: Pelvic Tumor
Date: 2016-12-15
Interventions: Radiation: Repeat CT scan
Completed Study Name: Treatment of Hemorrhagic Radiation Proctitis Using the Halo System
Condition: Pelvic Neoplasms
Date: 2010-04-13
Interventions: Device: HALO90 Ablation catheter FDA approved endoscopic device for use in coagulation of tissue in the
Recruiting Study Name: Malignant Pediatric Pelvic Tumors: A Retrospective Study
Condition:
  • Abdominal Neoplasms
  • Pelvic Neoplasms

Date: 2015-09-21
Completed Study Name: SGO Society of Gynecologic Oncologists Data Outcomes Project
Condition: Pelvic Tumor
Date: 2006-05-01
Completed Study Name: Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Condition:
  • Abdominal Neoplasms
  • Pelvic Neoplasms

Date: 2005-09-12
Interventions: Drug: Optison Intervention description:
Recruiting Study Name: Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors
Condition:
  • Cervical Cancer
  • Uterine Cancer
  • Ovarian Cancer

Date: 2016-10-17
Interventions: Device: PAMS I After general anesthesia, pressure sensor o
Recruiting Study Name: Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)
Condition:
  • Malignant Neoplasms of Bone and Articular Cartilage
  • Pelvic Tumor Date: 2017-04-21
    Interventions: Drug: Tranexamic Acid
  • Adul
Recruiting Study Name: Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
Condition: Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
Date: 2015-05-26
Interventions: Drug: Regorafenib Regorafenib will be packaged as 40 mg tablets in a bottle. Patients will be instructed
Completed Study Name: Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer
Condition: Gynaecologic or Digestive Pelvic Cancer
Date: 2009-07-07
Interventions:
  • Drug: Isolated pelvis perfusion

Active, not recruiting Study Name: A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Condition:
  • Abdominal Cancer
  • Pelvic Cancer

Date: 2007-06-27
Interventions: Other: Cardiopulmonary Exercise Testing (CPET) Pedaling on a Stationary Bicycle at 60 Revolutions Per Mi
Next >>>